1 0

    FDA FAERS Case Report – Oxervate (cenegermin-bkbj) for MAH Dompé farmaceutici S.p.A. (Case 24278461, Received 30-Aug-2024)

    FDA FAERS Case Report – Oxervate (cenegermin-bkbj) for MAH Dompé farmaceutici S.p.A. (Case 24278461, Received 30-Aug-2024)

    $69.00 USD
    $69.00 USD
    Sale Sold out
    Original Request Contents: Request the Case Report for FAERS Case 24278461 for Oxervate (cenegermin-bkbj), a serious case received on 30-Aug-2024, for MAH Dompé farmaceutici S.p.A.
    • Status: Pending Fast-Track Request
    • Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity

    NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

    View full details